04Mar
Global Private Equity Newsletter - Winter 2020 Edition: Deals in the Life Sciences Sector Article 1: Value Drivers and Risks
As the private equity industry matures, and the deal landscape becomes more competitive, private equity sponsors are becoming more prepared and capable of investing in sectors previously considered overly-regulated, requiring advanced chemistry or...
By:
Dechert LLP
Related
On February 27, 2020, the Ninth Circuit issued a long-anticipated decision in Rizo v. Yovino. Consis...
Read More >
The OFCCP opened the month of October by announcing three multimillion dollar settlements with major...
Read More >
In an effort to align its legislation with the broader standards of the New York City Human Rights L...
Read More >
What happens when a whistle blower provides detailed information about a burly Texan — with convict...
Read More >
The Federal Trade Commission's Premerger Notification Office (PNO) announced that, effective Monday,...
Read More >
The Washington Employment Security Department (ESD) has pushed back the first reporting deadline und...
Read More >